Workflow
星巴克中国股权出售进入倒计时
StarbucksStarbucks(US:SBUX) 虎嗅APP·2025-10-18 13:05

Core Viewpoint - Starbucks is in the final stages of selling a majority stake in its China business, with private equity giants Carlyle and local firm Boyu Capital as leading bidders, potentially valuing the business at around $4 billion, excluding ongoing franchise fees [2][4]. Group 1: Strategic Motives for Sale - The sale aims to generate over $5 billion in cash for Starbucks' global headquarters, which can be used for debt repayment, stock buybacks, or investments in other markets [4]. - The funds will be directly injected into Starbucks China for store expansion, digital transformation, and product development, enhancing its competitive position against local rivals like Luckin Coffee [4]. Group 2: Benefits of Local Partnerships - Both Carlyle and Boyu can provide valuable resources in government relations, store location, and supply chain management, which are crucial for foreign companies operating in China [5]. - Involving local shareholders will shorten decision-making processes, allowing Starbucks to respond more swiftly to market changes and develop a "Chinese brain" for operations [5][6]. Group 3: Competitive Landscape - Starbucks faces intense competition from Luckin Coffee, which has a significantly larger store network, making it more convenient for consumers [14]. - The pricing strategy of competitors like Kudai Coffee, which offers lower prices, poses a threat to Starbucks' premium pricing model [16]. Group 4: Transaction Structure - The deal structure allows Starbucks to retain up to 49% ownership, providing a balance of risk and control [9]. - This structure enables Starbucks to continue benefiting from growth in the Chinese market while maintaining brand integrity and operational standards [11][12]. Group 5: Challenges and Future Outlook - The sale represents a gamble for Starbucks; success could lead to a new growth trajectory in China, while failure may result in cultural clashes and brand dilution [18]. - The new capital infusion is expected to accelerate Starbucks China's expansion, intensifying competition in the coffee market [18][19].